Tufts study shows APOBEC enzymes, which normally help fight viral infections by mutating viral DNA, cause repeat expansions and are unusually active in the brains of Huntington’s patients.
A small molecule inhibitor is key to potentially reversing CTNNB1 syndrome, according to a new study from a School of Medicine professor and colleagues.